Affecting roughly 5,000 people in the U.S., C3 glomerulopathy and immune-complex MPGN are two rare glomerulopathies ...

Janux Therapeutics' cash runway is about 12 months; dilution is likely, and upcoming data from both JANX007 and JANX008 are ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused clinical-stage biopharmaceutical company, today issued a comprehensive update on its therapeutic pipeline. The Company detailed meaningful ...

Larsson and Molokanova shine in Ras Al Khaimah as both players fire five-under totals to win their respective divisions in the WAGR-counting junior championship presented by DP World.

Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now discovered a molecular-level resistance mechanism that begins to take hold as ...

Silevertinib delivers robust anti-tumor activity as demonstrated by an ORR of 60% and a CNS response rate of 86% in 43 1L NSCLC patients presenting with 35 different non-classical EGFR mutations; no ...

A surprising link between constipation and kidney decline led researchers to test lubiprostone, revealing that it can protect ...

Sangamo Therapeutics (SGMO) stock rises as the U.S. FDA accepts a rolling submission request for the firm's ST-920 gene ...

Special Report: Race Oncology has taken a significant step forward in the clinical development of its next-generation cancer ...

Surviving longer and remaining healthier in later life is influenced by many factors beyond classical blood lipids. A growing ...